States To Investigate Vytorin Marketing Ploys

Law360, New York (January 29, 2008, 12:00 AM EST) -- Merck & Co. and Schering-Plough Corp. face a rising tide of controversy over Vytorin, as the attorneys general of two states investigate whether the companies suppressed the results of a study that found that the drug worked no better than an older, cheaper drug to prevent the buildup of arterial plaque.

The first slap in the face came Monday, when New York Attorney General Andrew Cuomo subpoenaed the two companies for documents and information to determine whether they purposely withheld the results of the so-called Enhance...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.